FDA backs Pfizer COVID-19 boosters for seniors, high-risk
By MATTHEW PERRONE, LAURAN NEERGAARD and MIKE STOBBE Associated Press The U.S. has moved a step closer to offering booster doses of Pfizer’s COVID-19 vaccine to seniors and others at high risk from the virus. The Food and Drug Administration on Wednesday signed off on such shots as a way to shore up protection in
Continue Reading